SCHEMBL4900950

SCHEMBL4900950

CCc1ccc(S(=O)(=O)NCCc2ccc(OCc3ccc(C(F)(F)F)cc3)cc2)cc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADAMTS4 O75173 1/20 0.49
MMP13 P45452 1/20 0.49
ERBB2 P04626 2/20 0.47
ERBB4 Q15303 2/20 0.47
AR P10275 1/20 0.47
AKR1C3 P42330 1/20 0.46
BCL2L1 Q07817 1/20 0.45
MCL1 Q07820 1/20 0.45
MAOB P27338 2/20 0.45
TBXA2R P21731 1/20 0.44
TBXAS1 P24557 1/20 0.44
PPARA Q07869 1/20 0.43
MEN1 O00255 1/20 0.43
PKM P14618 1/20 0.43
KMT2A Q03164 1/20 0.43
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP14 P50281 1/20 0.43
ADAM17 P78536 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4904384 0.92 ERBB2 (0.49) ADAMTS4MMP13ERBB2ERBB4AR
SCHEMBL4903155 0.92 AKR1C3 (0.48) AKR1C3TBXA2RTBXAS1KMT2A
SCHEMBL4905297 0.90 ADAMTS4 (0.50) ADAMTS4MMP13ERBB2ERBB4AR
SCHEMBL4907097 0.90 ALDH1A1 (0.54) ADAMTS4AKR1C3TBXA2RTBXAS1PPARA
SCHEMBL4906061 0.87 MMP2 (0.53) AKR1C3TBXA2RTBXAS1MEN1PKM
SCHEMBL4906237 0.86 MAPT (0.47) AKR1C3MAOBTBXA2RTBXAS1MEN1
SCHEMBL4897713 0.85 ERBB2 (0.49) ADAMTS4MMP13ERBB2ERBB4AR
SCHEMBL4899749 0.84 ERBB2 (0.50) ADAMTS4MMP13ERBB2ERBB4AR
SCHEMBL4909044 0.84 AKR1C3 (0.46) AKR1C3TBXA2RTBXAS1KMT2A
SCHEMBL4895673 0.83 ALDH1A1 (0.46) AKR1C3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD ADAMTS4 4338/4885MMP13 3079/4885ERBB2 2776/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD ADAMTS4 4338/4885MMP13 3079/4885ERBB2 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.